Veli Topkara, MD, Cardiology, New York, NY, New York-Presbyterian Hospital

VeliKemalTopkaraMD

Cardiology New York, NY

Adult Congenital Heart Disease, Heart Failure & Transplantation

Physician

Overview of Dr. Topkara

Dr. Veli Topkara is a cardiologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Hacettepe University Faculty of Medicine and has been in practice 13 years. He is one of 361 doctors at New York-Presbyterian Hospital and one of 159 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Cardiology.

Education & Training

  • Washington University
    Washington UniversityFellowship, Cardiovascular Disease, 2009 - 2013
  • Baylor College of Medicine
    Baylor College of MedicineResidency, Internal Medicine, 2006 - 2009
  • Thomas Jefferson University
    Thomas Jefferson UniversityInternship, Transitional Year, 2005 - 2006
  • Hacettepe University Faculty of Medicine
    Hacettepe University Faculty of MedicineClass of 2004

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2013 - 2022
  • MO State Medical License
    MO State Medical License Active through 2013
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
  • American Board of Internal Medicine Cardiovascular Disease

Publications & Presentations

PubMed

Journal Articles

  • VA‐ECMO for Cardiogenic Shock in the Contemporary Era of Heart Transplantation: Which Patients Should Be Urgently Transplanted?  
    Yoshifumi Naka, Maryjane A Farr, Koji Takeda, Paolo Colombo, Hiroo Takayama, Arthur R Garan, Veli K Topkara, Clinical Transplantation

Authored Content

  • Trends in US Heart Transplant Waitlist Activity and Volume During the Coronavirus Disease 2019 (COVID-19) PandemicJuly 2020
  • Trends in US Heart Transplant Waitlist Activity and Volume During the Coronavirus Disease 2019 (COVID-19) PandemicJuly 2020
  • Outcomes Associated with Mammalian Target of Rapamycin (mTOR) Inhibitors in Heart Transplant Recipients: A Meta-Analysis☆March 2018
  • Outcomes Associated with Mammalian Target of Rapamycin (mTOR) Inhibitors in Heart Transplant Recipients: A Meta-Analysis☆March 2018
  • Prognostic Impact of Pulmonary Artery Pulsatility Index (PAPi) in Patients with Advanced Heart Failure: Insights from the ESCAPE TrialMarch 2018
  • Join now to see all

Press Mentions

  • Myocardial Recovery in Patients Receiving Contemporary Left Ventricular Assist Devices
    Myocardial Recovery in Patients Receiving Contemporary Left Ventricular Assist DevicesJune 2nd, 2016
  • International Genome-Wide Association Study Consortium Identifies Novel Loci Associated with Blood Pressure in Children and Adolescents
    International Genome-Wide Association Study Consortium Identifies Novel Loci Associated with Blood Pressure in Children and AdolescentsMarch 11th, 2016
  • Assessing Anticoagulation Practice Patterns in Patients on Durable Mechanical Circulatory Support Devices: An International Survey
    Assessing Anticoagulation Practice Patterns in Patients on Durable Mechanical Circulatory Support Devices: An International SurveyFebruary 28th, 2016

Hospital Affiliations